Unit­ed Ther­a­peu­tics bags a new OK on Ty­va­so, with block­buster ex­pec­ta­tions; Gilead goes back to Ab­Celler­a's well with ...

5 years ago
News Briefing

Why the Biden ad­min­is­tra­tion might not want to be con­tent with just an act­ing FDA com­mis­sion­er

5 years ago
Pharma
FDA+

Glax­o­SmithK­line of­floads roy­al­ty rights for 2 can­cer drugs in $342M wind­fall it will use to fi­nance con­sumer spin­off

5 years ago
Pharma

Bris­tol My­ers faces $1B+ tax fight af­ter ac­ci­den­tal dis­clo­sure re­veals al­leged off­shore patents scheme — re­port

5 years ago
Pharma
FDA+

Cut­ting loose from Mer­ck, Mike Nal­ly is 'run­ning to­ward a great op­por­tu­ni­ty'; No­var­tis part­ner­ship in hand, BeiGene ...

5 years ago
Peer Review

Covid-19 roundup: Emer­gen­t's er­ror costs J&J a vac­cine batch; Pfiz­er head says EU re­stric­tions slow vac­cine ...

5 years ago
Coronavirus
Manufacturing

In high­ly un­usu­al op-ed, 3 ad­u­canum­ab ad­comm mem­bers again call on FDA to re­ject Bio­gen's Alzheimer's drug

5 years ago
FDA+

Sanofi keeps nip­ping at J&J's heels as Sar­clisa notch­es new FDA ap­proval in mul­ti­ple myelo­ma

5 years ago
FDA+

US spe­cial coun­sel looks in­to al­leged mis­con­duct at Mer­ck plant prep­ping to make J&J shot — and in­dif­fer­ence from ...

5 years ago
Manufacturing

US gov­ern­ment does not own any remde­sivir patents, GAO re­port finds

5 years ago
R&D
Coronavirus

Pi­ra­mal Phar­ma So­lu­tions picks up In­di­an pep­tide API mak­er in push in­to on­col­o­gy, meta­bol­ic con­tract work

5 years ago
Outsourcing
Manufacturing

TCR² plants its flag in for­mer Au­to­lus man­u­fac­tur­ing site, plan­ning to add 175 jobs as it ad­vances lead T cell ...

5 years ago
R&D
Manufacturing

Rare blood clot events more com­mon among women re­ceiv­ing As­traZeneca Covid-19 vac­cine, EMA says

5 years ago
Coronavirus

FDA and EMA push ahead with joint ef­forts to kick-start pe­di­atric can­cer drug de­vel­op­ment plans

5 years ago
FDA+

Why do some tar­get­ed can­cer ther­a­pies stop work­ing? For Tyra, that's the $106M ques­tion

5 years ago
Financing

Move over, Boston and San Fran­cis­co? Seat­tle tops list of fastest grow­ing biotech hubs for job op­por­tu­ni­ties — ...

5 years ago
Pharma

Bausch Health sells off Amoun for $740M; Achilles de­buts on Nas­daq with $175.5M IPO

5 years ago
News Briefing

Look­ing to pre­pare for the next flu pan­dem­ic, Sanofi drops $700M+ in­to new Toron­to fa­cil­i­ty for Flu­zone pro­duc­tion

5 years ago
R&D
Manufacturing

Scribe, Jen­nifer Doud­na's newest start­up, nabs a mega-round and a vo­cal in­vestor

5 years ago
Financing

A pair of Lyell founders look to shift the cell ther­a­py par­a­digm — and they've got $30M to get their plan off the ...

5 years ago
Financing
Cell/Gene Tx

Bet­ting ear­ly on an AI niche, RA Cap­i­tal seeds a young founder's quest to un­lock 'Holy Grail' tar­gets

5 years ago
Financing
Startups

Biotech pi­o­neer and start­up in­vestor John Mar­tin, who built Gilead in­to a pow­er­house play­er, has died

5 years ago
People

Covid-19 roundup: As­traZeneca vac­cine halt­ed in Ger­many for be­low-60 pop­u­la­tion; Pfiz­er says Covid-19 vac­cine has ...

5 years ago
Coronavirus

Piv­ot­ing to­ward neu­ro­mus­cu­lar dis­eases and Duchenne, En­tra­da locks down $116M crossover round

5 years ago
Financing
First page Previous page 723724725726727728729 Next page Last page
A service from the Financial Times